Summary. In order to study the effects of normoglycaemia on diabetic retinopathy, 20 diabetic uraemic patients who underwent a kidney-pancreas transplantation were evaluated before and after surgery (6,9 months and once a year). The control group consisted of 12 uraemic patients who underwent kidney transplantation alone. At each follow-up examination a complete clinical examination and a retinal fluorescein angiography were performed. The eyes with end-stage retinopathy at baseline were excluded from the study.The analysis of the results showed no significant differences in the two groups.
of hypoglycaemia. The results of this technique have greatly improved recently (Sutherland 1987 ) and many groups are now evaluating its effect on long-term degenerative diabetic complications. We have studied the evolution of diabetic retinopathy in patients successfully submitted to a simultaneous pancreas and kidney transplantation. Twelve diabetic patients submitted to a kidney transplantation alone constituted the control group.
Subjects and methods
Twenty patients (39 eyes, 1 enueleated) submitted to a simultaneous kidney-pancreas transplantation from a cadaveric donor between July 1985 and August 1990 constituted the study group. The clinical characteristics of this group are shown in Table I . 
Introduction
The role of metabolic control on the evolution of diabetic retinopathy has been widely explained, although a clear correlation has not been established (Hanssen 1986; Siperstein 1983) .
A near normal glycaemic control is nowadays a possible target using one of following means: conventional insulin therapy and home blood sugar monitoring, multiple insulin injection or continuous subcutaneous insulin-delivery system.
The main disadvantage of strict metabolic control is hypoglycaemia, so that a near normoglycaemia is obtained at risk of a higher incidence of hypoglycaemic episodes.
Pancreas transplantation is a self-regulated source of insulin and the only means of obtaining a near physiologic metabolic control without the occurrence Sixteen patients received a segmental neoprene injected pancreas and 4 patients received a whole pancreas with bladder diversion. Immunosuppression consisted of anti-lymphocyte globulins, azathioprine, prednisone and cyctosporin. In all cases insulinindependence was achieved within 1 or 2 week after surgery. A good metabolic control was maintained during the follow-up (see Table 2 ). Table 1 , were comparable to the study group. Among them, 7 received a kidney transplantation alone and 5 received a simultaneous kidney and pancreas graft, but lost the pancreatic function within the first month after surgery ( mainly for technical reasons). Immunosuppression was the same in the study group. A good metabolic control was achieved with insulin therapy (multiple injection regimen in 4 cases and subcutaneous insulin infusion in 8 cases) throughout the follow-up.
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Ophthalmological evaluations. In both groups patients underceent an ophtalmological evaluation before surgery and 6 and 9 months and yearly intervals thereafter. The patients were divided into 3 groups, according to the follow-up (see Table 3 ). Table 3 . Mean variation of visual acuity in the study group and in the control group according to the follow-up S= study group, C~ control group amean + SD A complete ophthalmological examination, determination of the best corrected visual acuity and a fluorescein angiography were performed. The end point for data collection was the most recent examination performed for each patient. Fluorescein angiograms were evaluated by two different ophthahnologists separately. Angiograms were evaluated for : capillary closure, macular oedema, disk neovaseularization, neovascularization elsewhere, vitreous haemorrhage. Visual function was also examinated. The evaluations were performed separately in the 3 groups of follow-up (see Table 3 ). Nine eyes were excluded at baseline because of neovascular glaucoma or secondary retinal detachment. Ten eyes were ruled out from the study because one of the following eventualities occurred during the follow-up: laser treatment, cataract extraction, anterior ischaemie optic neuropathy, cytomegalovirus retinitis.
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Results
For the reasons mentioned above, 19 eyes in the study group (48.7%) and 11 eyes in the control group (47.8%) were ruled out from the study. In the study group the causes for the exclusion were: end stage retinopathy (9 eyes 47.3%), laser treatment (8 eyes 42.1%), cataract extraction + laser treatment (1 eye 5.3%), anterior ischaemic optic neuropatliy (1 eye 5.3%). In the control group, 10 eyes (90.9%) were excluded because of laser treatment and 1 (9.1%) because of cytomegalovirus endophthalmitis. Prior to surgery 14 eyes (70%) in the study group and 7 (58.3%) in the control group had been panphotocoagulated. No changes were observed in 18 eyes (90%) in the study group and in 8 eyes (66.7%) in the control group. Two eyes both in the study and in the control group showed a reduction of the macular oedema and capillary closure; 2 eyes in the control group showed an augmented capillary closure. The mean visual acuity did not change significantly in any group during the follow-up (see Table 3 ) nor did it change when each patient was considered separately or among the different groups of follow-up.
Discussion
The aim of this study was to evaluate the potential benefit of normoglycaemia on the evolution of diabetic retinopathy, as a mean to reverse or, at least, stabilize the ophthalmological complications of diabetes. The control group was comparable to the study group for age, diabetes duration, dialysis duration and immunosuppressive therapy. Our data show no difference between the study and the control group, and similar results had been reported by other authors (Petersen 1990; Ramsay 1988; Bandello 1989) . On the other hand, other groups have suggested positive effects of pancreas transplantation on diabetic retinopathy (Black 1981; Ulbig 1987; Konisgrainer 1986 ) If our results are not encouraging, we have to underline that the baseline ocular status of our patients was far advanced before surgery and maybe not susceptible to amelioration. Diabetic retinopathy substantially stabilized after kidney+pancreas or kidney transplantation, and an experienced ophthalmologist should be responsible for such a stabilization on followup. When end-stage diabetic nephropathy develops, it is often associated with severe retinal damage; until pancreas transplantation is performed at late stage of the disease, it will hardly exert a benefical effect on diabetic retinopathy.
